We found an increased expression of IL-22BP mRNA in the monocytes of 51 patients as compared to 30 HC (p = 0.016; Fig. 1i) and in the moDCs of a subset of 15 MS patients as compared to 10 HC (p = 0.016; Fig. 1k). This evidence concerns the gene IL22RA2 and myeloid sarcoma.